Patrick Frost, PhD

Patrick Frost, PhD

Feb 02, 2016

Group 6 Copy 32
0
Please wait...

About This Project

BBRI and Los Angeles VA Medical Center

Multiple myeloma (MM) is a cancer of the bone marrow made up of plasma cells (a type of antibody-producing white blood cells). Low oxygen levels (called hypoxia) in the bone marrow increases gene expression in MM tumor cells as part of an adaptive survival response. We are targeting this hypoxic response with an experimental drug that blocks expression of these genes to ask if this molecule kills MM in the bone marrow. This is a novel approach to treat MM, an incurable disease.

Blast off!

Browse Other Projects on Experiment

Related Projects

Sharks host bacteria, but what are they?

Shark microbiomes, the partial or collective genes from the microbial communities, remain under characterized...

Why be social? The costs and benefits of sociality in spiders

Sociality in spiders is extremely rare, but it has evolved several times. This begs the question: why be social...

Backer Badge Funded